Baseline characteristics of study participants
. | Iron group (n = 12) . | Saline group (n = 12) . |
---|---|---|
Age, y | 32 ± 11 | 33 ± 9 |
Height, cm | 166 ± 4 | 166 ± 6 |
Weight, kg | 73 ± 13 | 72 ± 9 |
End-tidal PO2, mmHg | 104 ± 8 | 106 ± 4 |
Arterial oxygen saturation, % | 99 ± 1 | 99 ± 1 |
Hematocrit, % | 47 ± 2 | 45 ± 2 |
Ferritin, ng/mL | 96 ± 69 | 90 ± 34 |
Transferrin saturation, % | 32 ± 9 | 31 ± 14 |
Hepcidin, ng/mL | 14 ± 11 | 14 ± 11 |
Growth differentiation factor-15, pg/mL | 532 ± 230 | 515 ± 177 |
Erythropoietin, mU/mL | 4.4 ± 1.9 | 7.0 ± 4.2 |
Soluble transferrin receptor, nmol/L | 20 ± 5 | 17 ± 4 |
. | Iron group (n = 12) . | Saline group (n = 12) . |
---|---|---|
Age, y | 32 ± 11 | 33 ± 9 |
Height, cm | 166 ± 4 | 166 ± 6 |
Weight, kg | 73 ± 13 | 72 ± 9 |
End-tidal PO2, mmHg | 104 ± 8 | 106 ± 4 |
Arterial oxygen saturation, % | 99 ± 1 | 99 ± 1 |
Hematocrit, % | 47 ± 2 | 45 ± 2 |
Ferritin, ng/mL | 96 ± 69 | 90 ± 34 |
Transferrin saturation, % | 32 ± 9 | 31 ± 14 |
Hepcidin, ng/mL | 14 ± 11 | 14 ± 11 |
Growth differentiation factor-15, pg/mL | 532 ± 230 | 515 ± 177 |
Erythropoietin, mU/mL | 4.4 ± 1.9 | 7.0 ± 4.2 |
Soluble transferrin receptor, nmol/L | 20 ± 5 | 17 ± 4 |
Values are mean ± SD.
PO2 indicates partial pressure of oxygen.